Analysen von Charmaine Chan
| 08.01.13 | Celgene kaufen | RBC Capital Markets | |
| 04.01.13 | Celgene halten | RBC Capital Markets | |
| 02.01.13 | Celgene halten | RBC Capital Markets | |
| 21.12.12 | Aveo Pharmaceuticals kaufen | RBC Capital Markets | |
| 17.12.12 | Infinity Pharmaceuticals outperform | RBC Capital Markets | |
| 17.12.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 17.12.12 | Amgen outperform | RBC Capital Markets | |
| 05.12.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 30.11.12 | Curis outperform | RBC Capital Markets | |
| 26.11.12 | Infinity Pharmaceuticals outperform | RBC Capital Markets | |
| 21.11.12 | Xoma outperform | RBC Capital Markets | |
| 21.11.12 | Infinity Pharmaceuticals outperform | RBC Capital Markets | |
| 20.11.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 20.11.12 | Aveo Pharmaceuticals outperform | RBC Capital Markets | |
| 15.11.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 09.11.12 | Seattle Genetics outperform | RBC Capital Markets | |
| 09.11.12 | InterMune sector perform | RBC Capital Markets | |
| 09.11.12 | Auxilium Pharmaceuticals outperform | RBC Capital Markets | |
| 06.11.12 | PDL BioPharma sector perform | RBC Capital Markets | |
| 06.11.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 06.11.12 | Celgene sector perform | RBC Capital Markets | |
| 02.11.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 22.10.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 15.10.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 12.10.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 12.10.12 | Celgene sector perform | RBC Capital Markets | |
| 10.10.12 | Cubist Pharmaceuticals outperform | RBC Capital Markets | |
| 08.10.12 | XenoPort outperform | RBC Capital Markets | |
| 08.10.12 | Sunesis Pharmaceuticals outperform | RBC Capital Markets | |
| 05.10.12 | Amgen outperform | RBC Capital Markets | |
| 04.10.12 | InterMune sector perform | RBC Capital Markets | |
| 27.09.12 | Elan outperform | RBC Capital Markets | |
| 27.09.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 21.09.12 | Biogen outperform | RBC Capital Markets | |
| 20.09.12 | Celgene sector perform | RBC Capital Markets | |
| 14.09.12 | Biogen outperform | RBC Capital Markets | |
| 13.09.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 13.09.12 | Elan outperform | RBC Capital Markets | |
| 13.09.12 | Sunesis Pharmaceuticals outperform | RBC Capital Markets | |
| 11.09.12 | Spectrum Pharmaceuticals outperform | RBC Capital Markets | |
| 06.09.12 | Ariad Pharmaceuticals outperform | RBC Capital Markets | |
| 03.09.12 | InterMune sector perform | RBC Capital Markets | |
| 03.09.12 | Biomarin Pharmaceutical outperform | RBC Capital Markets | |
| 31.08.12 | Amgen outperform | RBC Capital Markets | |
| 31.08.12 | ArQule outperform | RBC Capital Markets | |
| 30.08.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 29.08.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 29.08.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 28.08.12 | Biogen outperform | RBC Capital Markets | |
| 27.08.12 | ImmunoGen outperform | RBC Capital Markets | |